Keywords: cephalon, resubmits, myotrophin, nda, chiron, corp, withdrawn

Cephalon Resubmits Myotrophin NDA

Article | 13 November 1997

Print This

- Cephalon and Chiron Corp have withdrawn and resubmitted their NewDrug Application to the US Food and Drug Administration for Myotrophin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in